Judge Removes Block On Watson's Generic Yasmin

Law360, New York (September 3, 2010, 4:05 PM EDT) -- A federal court has effectively given Watson Pharmaceuticals Inc. the go-ahead to complete its application with the U.S. Food and Drug Administration to market a generic version of Bayer AG's oral contraceptive Yasmin.

In a ruling issued Thursday, Judge Paul G. Gardephe of the U.S. District Court for the Southern District of New York nixed Bayer's bid to extend an automatic 30-month block against Watson finalizing its application for generic Yasmin, finding that the German pharmaceutical company had failed to properly show that an extension was...
To view the full article, register now.